Barclays Maintains Equal-Weight on Teladoc Health, Raises Price Target to $9
Benzinga Newsdesk 5 hours ago
Analyst RatingsNewsPrice Target
Barclays analyst Glen Santangelo maintains Teladoc Health (NYSE:TDOC) with a Equal-Weight and raises the price target from $7 to $9.
Barclays analyst Glen Santangelo maintains Teladoc Health (NYSE:TDOC) with a Equal-Weight and raises the price target from $7 to $9.